Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy.

MLA

Ribera, Albert, et al. “Biochemical, Histological and Functional Correction of Mucopolysaccharidosis Type IIIB by Intra-Cerebrospinal Fluid Gene Therapy.” Human Molecular Genetics, vol. 24, no. 7, Apr. 2015, pp. 2078–95. EBSCOhost, https://doi.org/10.1093/hmg/ddu727.

APA

Ribera, A., Haurigot, V., Garcia, M., Marcó, S., Motas, S., Villacampa, P., Maggioni, L., León, X., Molas, M., Sánchez, V., Muñoz, S., Leborgne, C., Moll, X., Pumarola, M., Mingozzi, F., Ruberte, J., Añor, S., & Bosch, F. (2015). Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy. Human Molecular Genetics, 24(7), 2078–2095. https://doi.org/10.1093/hmg/ddu727

Chicago

Ribera, Albert, Virginia Haurigot, Miguel Garcia, Sara Marcó, Sandra Motas, Pilar Villacampa, Luca Maggioni, et al. 2015. “Biochemical, Histological and Functional Correction of Mucopolysaccharidosis Type IIIB by Intra-Cerebrospinal Fluid Gene Therapy.” Human Molecular Genetics 24 (7): 2078–95. doi:10.1093/hmg/ddu727.